Janssen Reports Positive Phase III Data for Chronic Diabetic Peripheral ... 
Genetic Engineering News
Janssen Pharmaceuticals reported Phase III results demonstrating the efficacy of Nucynta® ER (extended release tapentadol) in managing pain associated with chronic diabetic peripheral neuropathy (DPN). Janssen says the data is consistent with that of a ...
Positive Ph III results for J&J's Nucynta in diabetic peripheral neuropathy The Pharma Letter
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... PR Newswire (press release)

all 4 news articles » 

Slow diabetic neuropathy by keeping blood sugar controlled 
Sioux City Journal
My doctor says they're due to diabetic neuropathy. What is this? And what can I do about it? DEAR READER: Diabetic neuropathy is nerve damage that results from diabetes. The most common symptoms of neuropathy are tingling, burning, other unpleasant ...

and more » 

Tapentadol ER Effective for Moderate to Severe Chronic Diabetic Peripheral ... 
Monthly Prescribing Reference
HONOLULU, HI?Tapentadol extended-release (ER) is a safe and effective option for the management of moderate to severe neuropathic pain associated with diabetic peripheral neuropathy (DPN), investigators reported at the American Pain Society's 31 st ...
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... PipelineReview.com (press release)
J&J's Nucynta tackles pain in people with diabetes PMLiVE

all 10 news articles » 

Ask Dr. K: Lifestyle changes may help ED 
GoErie.com
They also are more likely to have neuropathy, or damage to the nerves that control how much blood enters and leaves the penis. If you have diabetes, controlling your blood sugar can help slow the neuropathy. - Trim your waistline and slim down.

and more » 

Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... 
MarketWatch (press release)
Over time, people with diabetes can develop a type of nerve damage called neuropathy. Approximately 60 to 70 percent of people with diabetes have some form of neuropathy(3). The most common type is diabetic peripheral neuropathy, which causes pain or ...

and more » 

Valley Presbyterian Hospital's Amputation Prevention Center Observes ... 
MarketWatch (press release)
VAN NUYS, Calif., May 14, 2012 (BUSINESS WIRE) -- In observance of Neuropathy Awareness Week, Dr. Lee C. Rogers, one of the specialists at Valley Presbyterian Hospital's Amputation Prevention Center, called today for Americans to guard against the ...

and more » 

Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic ... 
MarketWatch (press release)
NEW YORK, May 04, 2012 (BUSINESS WIRE) -- Pfizer Inc. (NYSE:PFE) announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized ...
Pfizer halts Lyrica Phase 3 Trial In Neuropathic Pain related to HIV Neuropathy RTT News
Pfizer Axes Late-Stage Lyrica Study Following Disappointing Results Fox Business
Pfizer's Lyrica Nerve-Pain Drug Fails To Meet Endpoint In Diabetes Study Wall Street Journal
Chicago Tribune 
all 156 news articles » 

Neuro diagnosis can ignite grief, mourning 
Hometownlife.com
Perhaps it is multiple sclerosis or Parkinson's disease or epilepsy or Huntington's disease or peripheral neuropathy. Or, for that matter, any other serious medical or psychological diagnosis. You can't flee. You can't protect yourself.

 

Diabetes and the Beaver 
Meriden Record-Journal
But peripheral neuropathy, in my case, is no big deal, so I'm really not complaining. Honest. In my case, it's mainly a matter of numbness in the fingers and toes, plus a bit of additional clumsiness (that is, additional to my natural clumsiness).

 

Pregabalin Fails to Improve Diabetic, HIV Neuropathy 
Medscape
May 8, 2012 ? A phase 3 clinical trial of pregabalin (Lyrica, Pfizer) failed to meet its primary endpoint of improvement in mean pain scores relative to baseline in patients with inadequately treated painful diabetic neuropathy, the company announced.
Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic ... EON: Enhanced Online News (press release)
Pfizer Drug Lyrica Fails in Phase 3 Study In Patients With Diabetic Peripheral ... A Sweet Life
Lyrica (pregabalin) No Good For Diabetes Or HIV Associated Neuropathic Pain Medical News Today
MedPage Today  -Washington Post  -MarketWatch 
all 44 news articles »